Company Filing History:
Years Active: 2021
Title: Innovations of Shuhua Tan in Hypoglycemic Fusion Proteins
Introduction
Shuhua Tan is a notable inventor based in Nanjing, China. He has made significant contributions to the field of medical science, particularly in the development of hypoglycemic agents. His work focuses on creating innovative solutions for diabetes management.
Latest Patents
Shuhua Tan holds a patent for a "High-activity long-acting hypoglycemic fusion protein as well as preparation method and medical application thereof." This patent describes a high-activity long-acting hypoglycemic fusion protein, which is formed by connecting, via a linker peptide or directly, a high-activity Exendin-4 mutant with an optimally mutated Fc fragment of a human immunoglobulin IgG1. The optimally mutated Fc fragment comprises an optimally mutated human IgG1 hinge region and human IgG1 constant regions CH2 and CH3. This innovation aims to enhance the efficacy of diabetes treatment.
Career Highlights
Shuhua Tan is affiliated with China Pharmaceutical University, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on diabetes care and treatment.
Collaborations
Shuhua Tan collaborates with esteemed colleagues, including Lili Gu and Jian Fu, who contribute to his research initiatives. Their combined expertise fosters a productive environment for innovation.
Conclusion
Shuhua Tan's contributions to the field of hypoglycemic agents exemplify the importance of innovation in medical science. His patent and ongoing research hold promise for improving diabetes management and patient outcomes.